FOXM1 influences DNA methylation to augment TACC3 alternative splicing directed by KAT2A in hepatocellular carcinoma

Key Points

• FOXM1 influences DNA methylation, enhancing TACC3 alternative splicing in hepatocellular carcinoma.
• Key evidence shows that inhibiting TACC3 can synergistically disrupt mitotic fidelity and transcriptional regulation.
• Analysis focused on the interactions between TACC3 and KAT2A, revealing crucial regulatory pathways in cancer.
• This highlights a potential therapeutic avenue with reduced toxicity, signaling a need for further exploration in clinical applications.